- Title: Subtitle
- POSTER: ABCL-612 Real-World Outcomes in Patients With Relapsed or Refractory (r/r) Aggressive Large B-Cell Lymphoma (LBCL) Treated With Chemo-Immunotherapy
- Creators
- Loretta J. NastoupilClark AndersenAmy AyersYucai WangThomas M. HabermannDai ChiharaBrad S. KahlBrian K. LinkSabarish AyyappanJonathon B. CohenPeter MartinIzidore S. LossosCarla CasuloRuitao LinZiyi LiMelissa A. LarsonMatthew J. MaurerLynn HuynhChi GaoRamya RamasubramanianMei ShengAlex MutebiTongsheng WangMonika JunAnthony WangRajesh KamalakarAnupama KalsekarJames R. CerhanChristopher R. Flowers
- Resource Type
- Abstract
- Publication Details
- Clinical lymphoma, myeloma and leukemia, Vol.23(Suppl. 1), pp.S204-S204
- Publisher
- Elsevier Inc
- DOI
- 10.1016/S2152-2650(23)00723-1
- ISSN
- 2152-2650
- eISSN
- 2152-2669
- Language
- English
- Date published
- 09/2023
- Academic Unit
- Internal Medicine; Hematology, Oncology, and Blood & Marrow Transplantation; Epidemiology
- Record Identifier
- 9984461349902771
Abstract
POSTER: ABCL-612 Real-World Outcomes in Patients With Relapsed or Refractory (r/r) Aggressive Large B-Cell Lymphoma (LBCL) Treated With Chemo-Immunotherapy
Clinical lymphoma, myeloma and leukemia, Vol.23(Suppl. 1), pp.S204-S204
09/2023
DOI: 10.1016/S2152-2650(23)00723-1
Details
Metrics
1 Record Views